EUCTR2007-005242-21-GB进行中（未招募）不适用
A pilot study of replacement therapy with recombinant TSH in central hypothyroidism
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients aged between 20 and 60 years suffering from hypothyroidism due to hypopituitarism with their thyroid function showing low freeT4 and undetectable TSH will be included.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Age <20 or >60 years
- •- Inability to give informed consent
- •- Thyrotoxicosis
- •- Severe concomitant illness with significant impact on life expectancy
- •- Active acromegaly or Cushing's disease
- •- Cardiac arrhythmias or ischaemic heart disease
- •- Treatment with Amiodarone or Lithium within the last 6 months
- •- Current treatment with: L-Tri-iodothyronine, Carbimazole, Propylthiouracil or HRT.
- •- Pregnancy
- •- Breast feeding
- •- Women in child bearing age planning pregnancy
- •- Hypersensitivity to bovine or human thyroid stimulating hormone or to any of the excipients.
研究者
相似试验
进行中（未招募）
不适用
Phase II clinical study for the therapy of cystic fibrosis patients with aspecific mutatioCystic fibrosis patients with F508del-CFTR in homozygous or compound heterozygous with Class I or II mutationsEUCTR2013-001258-82-ITEuropean Institute for Cystic Fibrosis Research (IERFC)
已完成
不适用
Pilot trial: Renal replacement therapy in patients with acute kidney injury and rhabdomyolysisDRKS00023998niversitätsklinikum Leipzig AöR Interdisziplinäre Internistische Intensivmedizin Leiter: Prof. Dr. med. Sirak Petros15
已完成
不适用
Effect of rereading of written scenario on selection of delivery methodDelivery.Single spontaneous delivery, Single delivery by caesarean sectionO80, O82IRCT2015052020706N2Vice chancellor for research, Shahroud University of Medical Sciences and Health Services213
进行中（未招募）
不适用
A pilot study to investigate the use of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease.Inflammatory Bowel Disease (IBD) is the comprehensive term for disorders involving chronic inflammation in the gastrointestinal tract, often the small intestine and colon. It is believed to be a disorder mediated by T lymphocytes that arise in genetically susceptible persons as a result of a breakdown in the regulatory constraints on mucosal immune responses to enteric bacteria. Evidence suggests that Th1 T cells play an important pathogenetic role in Crohn´s disease.Level: PTClassification code 10011401EUCTR2005-002048-25-SESBL Vaccin AB25
已完成
3 期
A Phase III study on the regenerative treatment of tympanic membrane with NPC-18 and FBG-18-multicenter,investigator initiated clinical trial.Tympanic membrane perforation(TMP)JPRN-UMIN000017622Foundation for Biomedical Research and Innovation20